Stay updated on LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Sign up to get notified when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.

Latest updates to the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page
- CheckyesterdayChange DetectedThe page revision identifier was updated from v3.6.5 to v3.6.6, representing a new release of the page; no specific content changes to the study details are indicated.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the page version. This does not modify the study content or its details.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page now displays Revision: v3.6.4, indicating a version update. The study content and details remain unchanged.SummaryDifference0.1%

- Check58 days agoChange DetectedA newer revision version (v3.6.3) is displayed, indicating a minor page update without substantive changes to the study details.SummaryDifference0.1%

- Check65 days agoChange DetectedThe revision was updated from v3.6.0 to v3.6.2. This appears to be a minor backend update that does not modify the study details displayed on the page.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page adds new sections How to Read a Study Record, Common Questions, and How to Join a Study, and updates the Intervention/Treatment label to align with the content structure. These changes reorganize and clarify how readers access guidance and understand the study details.SummaryDifference0.5%

Stay in the know with updates to LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.